Principal Financial Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $92.5K | Sell |
|
|||||
|
2024
Q4 | $115K | Sell |
|
|||||
|
2024
Q3 | $127K | Sell |
|
|||||
|
2024
Q2 | $180K | Sell |
|
|||||
|
2024
Q1 | $254K | Buy |
|
|||||
|
2023
Q4 | $97.9K | Sell |
|
|||||
|
2023
Q3 | $69.3K | Sell |
|
|||||
|
2023
Q2 | $115K | Sell |
|
|||||
|
2023
Q1 | $121K | Sell |
|
|||||
|
2022
Q4 | $69K | Buy |
|
|||||
|
2022
Q3 | $84K | Sell |
|
|||||
|
2022
Q2 | $83K | Buy |
|
|||||
|
2022
Q1 | $69K | Buy |
|
|||||
|
2021
Q4 | $91K | Sell |
|
|||||
|
2021
Q3 | $1.46M | Buy |
|
|||||
|
2021
Q2 | $2.06M | Buy |
|
|||||
|
2021
Q1 | $484K | Sell |
|
|||||
|
2020
Q4 | $628K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $2.27M | Sell |
|
|||||
|
2014
Q4 | $2.92M | Buy |
|